SEDAM tablete
Back to products
Betamox LA
Click to enlarge

Syvaquinol 100

Syva

General information

target species

cow
usage

injectable
brand

Syva
manufacturer country

spain

Treatment of respiratory tract infections. Treatment of acute severe mastitis. Treatment of gastrointestinal tract infections. Treatment of septicaemia. Treatment of acute arthritis

This page is only to introduce the product for use by the authorized veterinary centers of the country and the sale is not done online. For more information and to order the product, please contact the company.

Product Description

  • Composition:

Enrofloxacin 100 mg /ml

·  Indications of use:

Treatment of respiratory tract infections caused by strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma spp. Susceptible to enrofloxacin.
Treatment of acute severe mastitis caused by enrofloxacin-susceptible strains of Escherichia coli.
Treatment of gastrointestinal tract infections caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin-susceptible strains of Escherichia coli.
Treatment of acute mycoplasma-associated arthritis caused by enrofloxacin-susceptible strains of Mycoplasma bovis in cattle under 2 years of age.

·  Dosage and route of administration:

  • 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 3-5 days.
  • Acute mycoplasma-associated arthritis,caused by enrofloxacin-susceptible strains of Mycoplasma bovis
  • in cattle under 2 years of age: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 5 days.
  • The veterinary medicinal product can be administered by slow intravenous or subcutaneous administration.
  • Acute mastitis caused by Escherichia coli:5 mg enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, by slow intravenous injection once daily for two consecutive days.
  • The second dose may be administered by the subcutaneous route. In this case, the withdrawal period following subcutaneous injection applies.
  • No more than 10 ml should be administered at one subcutaneous injection site.

  • contraindications:

  • Do not use in case of known hypersensitivity to fluoroquinolones or to any of the excipients.
  • Do not use in growing horses because of possible damage to articular cartilage.

·   Precautions:

  • When using this veterinary medicinal product, the official recommendations on the use of antimicrobials should be taken into account.
  • Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
  • Whenever possible, fluoroquinolones should be used after performing a sensitivity
  • Use of the product including use deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to enrofloxacin and may decrease the effectiveness of treatment with other fluoroquinolones due to cross-resistance.

  • Storage methods:

  • Keep away from children.
  • Store in a cool place away from light.

  • Presentation:

Box with 1 glass 100 mL vial

  • Manufacturer:

Syva , Spain

 

 

 

 

 

 

Product Information

target species

cow
usage

injectable
brand

Syva
manufacturer country

spain

Product Description

  • Composition:

Enrofloxacin 100 mg /ml

·  Indications of use:

Treatment of respiratory tract infections caused by strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma spp. Susceptible to enrofloxacin.
Treatment of acute severe mastitis caused by enrofloxacin-susceptible strains of Escherichia coli.
Treatment of gastrointestinal tract infections caused by enrofloxacin susceptible strains of Escherichia coli.
Treatment of septicaemia caused by enrofloxacin-susceptible strains of Escherichia coli.
Treatment of acute mycoplasma-associated arthritis caused by enrofloxacin-susceptible strains of Mycoplasma bovis in cattle under 2 years of age.

·  Dosage and route of administration:

  • 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 3-5 days.
  • Acute mycoplasma-associated arthritis,caused by enrofloxacin-susceptible strains of Mycoplasma bovis
  • in cattle under 2 years of age: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 5 days.
  • The veterinary medicinal product can be administered by slow intravenous or subcutaneous administration.
  • Acute mastitis caused by Escherichia coli:5 mg enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, by slow intravenous injection once daily for two consecutive days.
  • The second dose may be administered by the subcutaneous route. In this case, the withdrawal period following subcutaneous injection applies.
  • No more than 10 ml should be administered at one subcutaneous injection site.

  • contraindications:

  • Do not use in case of known hypersensitivity to fluoroquinolones or to any of the excipients.
  • Do not use in growing horses because of possible damage to articular cartilage.

·   Precautions:

  • When using this veterinary medicinal product, the official recommendations on the use of antimicrobials should be taken into account.
  • Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials.
  • Whenever possible, fluoroquinolones should be used after performing a sensitivity
  • Use of the product including use deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to enrofloxacin and may decrease the effectiveness of treatment with other fluoroquinolones due to cross-resistance.

  • Storage methods:

  • Keep away from children.
  • Store in a cool place away from light.

  • Presentation:

Box with 1 glass 100 mL vial

  • Manufacturer:

Syva , Spain